ATE226571T1 - Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen - Google Patents

Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen

Info

Publication number
ATE226571T1
ATE226571T1 AT00401268T AT00401268T ATE226571T1 AT E226571 T1 ATE226571 T1 AT E226571T1 AT 00401268 T AT00401268 T AT 00401268T AT 00401268 T AT00401268 T AT 00401268T AT E226571 T1 ATE226571 T1 AT E226571T1
Authority
AT
Austria
Prior art keywords
optionally substituted
retinol
rings
saturated
unsaturated
Prior art date
Application number
AT00401268T
Other languages
English (en)
Inventor
Remy Tuloup
Gilles Rubinstenn
Maria Dalko
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9546210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE226571(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE226571T1 publication Critical patent/ATE226571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/12—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT00401268T 1999-06-01 2000-05-05 Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen ATE226571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9906872A FR2794457B1 (fr) 1999-06-01 1999-06-01 Derives carbonates de retinol, procede de preparation et utilisations

Publications (1)

Publication Number Publication Date
ATE226571T1 true ATE226571T1 (de) 2002-11-15

Family

ID=9546210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00401268T ATE226571T1 (de) 1999-06-01 2000-05-05 Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen

Country Status (8)

Country Link
US (2) US6331535B1 (de)
EP (1) EP1057809B1 (de)
JP (1) JP3576927B2 (de)
AT (1) ATE226571T1 (de)
CA (1) CA2309796C (de)
DE (1) DE60000635T2 (de)
ES (1) ES2185543T3 (de)
FR (1) FR2794457B1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811567B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
FR2811563B1 (fr) * 2000-07-13 2003-06-20 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive, et au moins un compose augmentant la synthese des glycosaminoglycanes
FR2819427B1 (fr) * 2001-01-18 2003-04-11 Oreal Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
DE10115840A1 (de) * 2001-03-30 2002-10-10 Basf Ag Retinylcarbonate in Kosmetika und Dermatika
US20030229158A1 (en) * 2001-09-28 2003-12-11 Chen Jen Chi Polymer composition and dosage forms comprising the same
FR2837704B1 (fr) * 2002-04-02 2005-01-14 Oreal Utilisation d'une sapogenine, ou un extrait naturel en contenant, pour le traitement des peaux seches oligoseborrheiques
US7008929B2 (en) * 2002-04-02 2006-03-07 L'oreal Sapogenin-based treatment
FR2838344B1 (fr) * 2002-04-12 2005-06-17 Oreal Utilisation d'une sapogenine, ou d'un extrait naturel contenant, pour lisser les rides et ridules d'expression
US7354956B2 (en) 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
EP1369411A1 (de) * 2002-06-07 2003-12-10 Cognis France S.A. Kosmetische und/oder pharmazeutische Zubereitungen mit Retinolestern
KR20040040792A (ko) * 2002-11-08 2004-05-13 주식회사 엘지생활건강 아미노산 또는 펩타이드가 결합된 레티놀 유도체 및 이를포함하는 피부노화 방지용 화장료 조성물
WO2006098966A2 (en) * 2005-03-09 2006-09-21 Combe Incorporated Stable mixed emulsions comprising semisolid dispersions of at least two discrete and distinctly different particle size ranges
US20070065390A1 (en) * 2005-09-19 2007-03-22 Eric Spengler Stable emulsion systems with high salt tolerance
EP1971865B1 (de) 2006-01-10 2013-04-17 Colgate-Palmolive Company Verfahren zur modulierung von zelloberflächenrezeptoren zur verhinderung oder abschwächung von entzündungen
TWI481870B (zh) 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記
US10426752B2 (en) 2009-04-01 2019-10-01 Colgate-Palmolive Company Menthol-derivative compounds and use thereof as oral and systemic active agents
AR076177A1 (es) 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
MY163501A (en) * 2009-04-01 2017-09-15 Colgate Palmolive Co Anti-biofilm carbonate compouns for use in oral care compositions
US11865197B2 (en) 2020-06-30 2024-01-09 L'oreal Cosmetic compositions having stabilized retinol
US11534381B2 (en) 2020-06-30 2022-12-27 L'oreal Cosmetic composition for improved penetration
US11819560B2 (en) 2020-08-31 2023-11-21 L'oreal Cosmetic compositions, kits thereof, and methods for making and using the same
US12083207B2 (en) 2020-08-31 2024-09-10 L'oreal Cosmetic compositions, kits thereof, and methods for making and using the same
US12090224B2 (en) 2021-10-31 2024-09-17 L'oreal Cosmetic composition comprising high amounts of ceramide-np
EP4422579A1 (de) 2021-10-31 2024-09-04 L'oreal Kosmetische zusammensetzungen mit hohem gehalt an hydroxypropyltetrahydropyrantriol
US12064504B2 (en) 2021-10-31 2024-08-20 L'oreal Cosmetic compositions comprising high amounts of trifluoromethylhenyl valylglycine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE191444T1 (de) * 1993-12-15 2000-04-15 Avon Prod Inc Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
JP3444326B2 (ja) * 1995-12-29 2003-09-08 ソニー株式会社 遠紫外線用ポジ型レジスト組成物

Also Published As

Publication number Publication date
EP1057809A1 (de) 2000-12-06
EP1057809B1 (de) 2002-10-23
US6331535B1 (en) 2001-12-18
US20020019547A1 (en) 2002-02-14
FR2794457A1 (fr) 2000-12-08
ES2185543T3 (es) 2003-05-01
US6384025B2 (en) 2002-05-07
DE60000635D1 (de) 2002-11-28
CA2309796C (fr) 2004-02-24
JP3576927B2 (ja) 2004-10-13
JP2001019669A (ja) 2001-01-23
DE60000635T2 (de) 2003-03-20
FR2794457B1 (fr) 2001-08-10
CA2309796A1 (fr) 2000-12-01

Similar Documents

Publication Publication Date Title
ATE226571T1 (de) Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen
ATE124405T1 (de) 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel.
DK0414263T3 (da) Fremgangsmåde til stabilisering af et fast farmaceutisk præparat indeholdende cycliske aminosyrer
DK0460917T3 (da) Fremgangsmåde til fremstilling af eicosapentaensyre eller et esterderivat deraf
ATE228132T1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
DE69310204D1 (de) Salpetersäureester mit pharmazeutischer wirkung und verfahren zu deren herstellung
NO951775D0 (no) Nye 3,3-difenylpropylaminer, deres anvendelse og fremstilling
BR1100061A (pt) Composto, processo para a preparação do mesmo, composição e uso dos mesmos
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
PT97773A (pt) Processo para a preparacao de oxazolidinonas e de composicoes farmaceuticas que as contem
AR017172A1 (es) Compuestos derivados de 3,4-diariltiazolina-2-ona o 2-tiona un metodo para su preparacion y composiciones farmaceuticas que los comprenden
IL75116A (en) Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same
ATE123773T1 (de) 1,3,5-triazin-2,4,6-tris- alkylaminocarbonsäureaminoester, diese enthaltende biozide mittel sowie verfahren zu ihrer herstellung.
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
DE69414695D1 (de) Glutaminsäure-derivate, ein verfahren zu ihrer herstellung und ihre verwendung zur steigerung des erinnerungsvermögens und der lernfähigkeit
IT1254996B (it) Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
DK314289A (da) Kompositioner
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
DE68911616D1 (de) Piperazin-Derivate und Verfahren zu deren Herstellung.
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
ATE192144T1 (de) Neue pilocarpinderivate und verfahren zu ihrer herstellung
ATE120450T1 (de) Verfahren zur herstellung von geschützten aza- yperiten prodrugs.
PL338294A1 (en) Derivatives of streptogramins, method of obtaining them and compositions containing such derivatives
ATE123529T1 (de) Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1057809

Country of ref document: EP

REN Ceased due to non-payment of the annual fee